Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis Read more
INOVIO’s COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models Read more
Tolero Pharma Submits Investigational New Drug Application for Experimental PKM2 Activator TP-1454 Read more
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology Read more
Phlow Corporation Awarded $354 Million Contract to Manufacture Essential Medicines in Shortage Read more